JPS52106857A - Preparation of 1,3-disubstituted-2-azetidinones - Google Patents

Preparation of 1,3-disubstituted-2-azetidinones

Info

Publication number
JPS52106857A
JPS52106857A JP16037776A JP16037776A JPS52106857A JP S52106857 A JPS52106857 A JP S52106857A JP 16037776 A JP16037776 A JP 16037776A JP 16037776 A JP16037776 A JP 16037776A JP S52106857 A JPS52106857 A JP S52106857A
Authority
JP
Japan
Prior art keywords
azetidinones
disubstituted
preparation
novel
methyleneamines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP16037776A
Other languages
English (en)
Japanese (ja)
Other versions
JPS613785B2 (enrdf_load_stackoverflow
Inventor
Takashi Kamiya
Shinji Hashimoto
Osamu Nakaguchi
Teruo Oku
Yoshiharu Nakai
Shuichi Takeno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS52106857A publication Critical patent/JPS52106857A/ja
Publication of JPS613785B2 publication Critical patent/JPS613785B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/24Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/25Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/085Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C07D205/09Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
    • C07D205/095Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4 and with a nitrogen atom directly attached in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/04Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP16037776A 1976-01-05 1976-12-29 Preparation of 1,3-disubstituted-2-azetidinones Granted JPS52106857A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB24276 1976-01-05

Publications (2)

Publication Number Publication Date
JPS52106857A true JPS52106857A (en) 1977-09-07
JPS613785B2 JPS613785B2 (enrdf_load_stackoverflow) 1986-02-04

Family

ID=9700935

Family Applications (1)

Application Number Title Priority Date Filing Date
JP16037776A Granted JPS52106857A (en) 1976-01-05 1976-12-29 Preparation of 1,3-disubstituted-2-azetidinones

Country Status (4)

Country Link
JP (1) JPS52106857A (enrdf_load_stackoverflow)
BE (1) BE850085A (enrdf_load_stackoverflow)
DE (1) DE2700178A1 (enrdf_load_stackoverflow)
FR (1) FR2357543A1 (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT389695B (de) * 1981-10-23 1990-01-10 Roussel Uclaf Verfahren zur herstellung von neuen 3-amino-2-oxo-azetidin-1-sulfonderivaten
JPS60139667A (ja) * 1983-12-27 1985-07-24 Takeda Chem Ind Ltd アゼチジノンの製造法
GB8503193D0 (en) * 1985-02-08 1985-03-13 Shell Int Research Azetidine derivatives

Also Published As

Publication number Publication date
FR2357543B1 (enrdf_load_stackoverflow) 1979-08-24
DE2700178A1 (de) 1977-07-14
JPS613785B2 (enrdf_load_stackoverflow) 1986-02-04
BE850085A (fr) 1977-07-04
FR2357543A1 (fr) 1978-02-03

Similar Documents

Publication Publication Date Title
JPS52106857A (en) Preparation of 1,3-disubstituted-2-azetidinones
JPS5231094A (en) Preparation of cephalexin
JPS5231059A (en) Preparation of oxybenzoylbenzoic acids
JPS5398918A (en) Preparation of gamma-pyrone derivatives
JPS53127891A (en) Crystallization of co-enzyme q
JPS52111587A (en) Preparation of 6-aminopenam carboxylic acid-1-oxide or its derivatives
JPS53103412A (en) Preparation of farnesyl acetic acid or its ester
JPS52142089A (en) Preparation of cephalosporanic acid derivatives
JPS52156879A (en) Preparation of piperazine derivatives
JPS5412350A (en) Preparation of trans-chrysanthemum-monocarboxylic acid chloride
JPS5239665A (en) Process for preparing perfluorolactones
JPS52153915A (en) Preparation of alpha-amino-delta-hydroxyvaleric acid
JPS5359638A (en) Preparation of adrenalone
JPS5379883A (en) Preparation of uracil
JPS52122388A (en) Preparation of 7-amino-3-carbamoyloxymethyl-3-cephem-4-carboxylic acid derivatives
JPS5253854A (en) Preparing optical active pyprolidine ethanols
JPS5283344A (en) Synthesis of 3-chloro-4-allyloxyphenyl-acetic acid
JPS51138681A (en) Process for preparing 1-carboxybenzopyrans
JPS5295610A (en) Preparation of alpha-thioamino acid derivatives
JPS5223067A (en) Novel synthesis of 2-aminomethyl-1- ethylpyrrolidine
JPS53149975A (en) Preparation of imidazolylbenzophenones
JPS5231093A (en) Preparation of 3- methylenecephalosporanic acid derivatives
JPS5334772A (en) Preparation of 2-benzothiazolines
JPS5242853A (en) Process for preparation of dihalovinylcyclopropanecaboxylic acid ester s
JPS5293755A (en) Preparation of carboxylic acid derivatives